Aviron Message Board - Msg: 11967009

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.250

+0.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Copeland who wrote (506)	11/17/1999 10:55:00 AM
From: Edscharp	Read Replies (1) of 645

Copeland, I phrased my response the way I did because of the following statement from the recent news releases. "The company said it is investigating some of the tests and will determine the need for any additional validation work on the test or the manufacturing process. Aviron said that Medeva Pharma Ltd., a unit of Medeva Plc (NYSE: MDV) which manufactures components of the vaccine, has notified Aviron of facilities compliance issues at its facility near Liverpool." As is usual with releases of this kind one can make mulitple interpretations or read too deeply into the phraseology, however, I took the above to simply mean that Aviron would proceed cautiously and investigate any additional compliance issues that might prevent final approval. One could read deeper into the statement and hypothesize that Medeva (or Aviron) has discovered a potential problem in the area of vaccine manufacturing, but I would hope if this was the concern that Aviron would be more plain and honest with it's shareholders. But, I appreciate that this isn't always the case. I will admit, it's not clear whether Aviron is simply being thorough or if an "avoidable problem" has popped up.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next